Table S1 - Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer

Patient characteristics of all patient groups used in combined-marker analyses. Patient characteristics are shown for all patient groups as used in the combined-marker analyses. The patient groups show comparable patient characteristics to the complete study cohort of 247 patients (Table 1). P-values represent the Jonckheere-Terpstra test used to test if samples came from the same distribution. For the variable "tumor size", a one-way ANOVA test was performed to test for statistical differences between the patient groups.
(DOC)